Mesoblast Clear To Proceed With Angioblast Acquisition
Filed with ASX · · 1 page · English
Story so far
Earlier from Mesoblast
- Revascor Increases Blood Supply to Damaged Heart Muscle
- Mesoblast Included in S and P/ASX 200 Index
- Key Product Franchises Featured at Nomura Asia Equity Forum
- FDA Clears Phase 2 Trial to Treat Degenerative Disc Disease
- Cardiac Events, Mortality and Hospitalization Reduced
Later from Mesoblast
- Key Bone Repair Patent Granted in the United States
- Market Exclusivity Strengthened by New USA Healthcare Act
- MSB partner JCR files for product approval
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast